Tim Anderson
Stock Analyst at Wolfe Research
(1.75)
# 2,095
Out of 4,496 analysts
7
Total ratings
100%
Success rate
15.83%
Average return
Main Sectors:
Top Industries:
4 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABBV AbbVie | Downgrades: Peer Perform | n/a | $172.32 | - | 3 | Feb 22, 2023 | |
| MRK Merck & Co. | Upgrades: Outperform | $127 | $125.77 | +0.98% | 2 | Feb 22, 2023 | |
| NVS Novartis AG | Downgrades: Peer Perform | n/a | $106.13 | - | 1 | May 9, 2022 | |
| AZN AstraZeneca | Upgrades: Outperform | n/a | $78.71 | - | 1 | Sep 22, 2017 |
AbbVie
Feb 22, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $172.32
Upside: -
Merck & Co.
Feb 22, 2023
Upgrades: Outperform
Price Target: $127
Current: $125.77
Upside: +0.98%
Novartis AG
May 9, 2022
Downgrades: Peer Perform
Price Target: n/a
Current: $106.13
Upside: -
AstraZeneca
Sep 22, 2017
Upgrades: Outperform
Price Target: n/a
Current: $78.71
Upside: -